Cargando…
Salinomycin decreases feline sarcoma and carcinoma cell viability when combined with doxorubicin
BACKGROUND: Cancer is a significant health threat in cats. Chemoresistance is prevalent in solid tumors. The ionophore salinomycin has anti-cancer properties and may work synergistically with chemotherapeutics. The purpose of our study was to determine if salinomycin could decrease cancer cell viabi...
Autores principales: | Borlle, Lucia, Dergham, Abdo, Wund, Zacharie, Zumbo, Brittany, Southard, Teresa, Hume, Kelly R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6346515/ https://www.ncbi.nlm.nih.gov/pubmed/30678671 http://dx.doi.org/10.1186/s12917-019-1780-5 |
Ejemplares similares
-
Biological indicators of chemoresistance: an ex vivo analysis of γH2AX and p53 expression in feline injection-site sarcomas
por: Bing, Yike, et al.
Publicado: (2018) -
Salinomycin increases chemosensitivity to the effects of doxorubicin in soft tissue sarcomas
por: Liffers, Sven-T, et al.
Publicado: (2013) -
Salinomycin enhances doxorubicin-induced cytotoxicity in multidrug resistant MCF-7/MDR human breast cancer cells via decreased efflux of doxorubicin
por: KIM, KWANG-YOUN, et al.
Publicado: (2015) -
Neoadjuvant and adjuvant doxorubicin chemotherapy in a case of feline
soft tissue sarcoma
por: Torrigiani, Filippo, et al.
Publicado: (2019) -
Salinomycin decreases doxorubicin resistance in hepatocellular carcinoma cells by inhibiting the β-catenin/TCF complex association via FOXO3a activation
por: Zhou, Yue, et al.
Publicado: (2015)